Skeletal muscle relaxation in general anaesthesia

Active Ingredient: Vecuronium

Indication for Vecuronium

Population group: only newborns (0 - 40 days old) , infants (40 days - 1 year old)

Vecuronium is indicated as an adjunct to general anaesthesia to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery in adults, neonates, infants, children and adolescents.

For this indication, competent medicine agencies globally authorize below treatments:

0.01-0.10 mg/kg

Route of admnistration

Intravenous

Defined daily dose

0.01 - 0.1 mg per kg of body weight

Dosage regimen

From 0.01 To 0.1 mg per kg of body weight once every day

Detailed description

Neonates (0–27 days) and infants (28 days-23 months)

Because of the possible variations of the sensitivity of the neuromuscular junction, especially in neonates and probably in infants up to 4 months of age, an initial test dose of 10–20 micrograms vecuronium bromide per kg body weight followed by incremental doses until 90 to 95% depression of twitch response is achieved is recommended. In neonatal surgery the dose should not exceed 100 micrograms/kg.

Dose requirements in older infants (5-23 months) are the same as in adults. However, since the onset time of vecuronium in these patients is considerably shorter than in adults and children, the use of high intubating doses in general is not required for early development of good intubating conditions.

Since the duration of action and recovery time with vecuronium is longer in neonates and infants than in children and adults, maintenance doses are required less frequently.

Preterm newborn infants

There are insufficient data to support dose recommendations for the use of vecuronium bromide in preterm newborn infants.

Active ingredient

Vecuronium

Vecuronium is a non-depolarising neuromuscular blocking agent. Vecuronium blocks the transmission process between the motor nerve-ending and striated muscle by binding competitively with acetylcholine to the nicotinic receptors located in the motor end-plate region of striated muscle.

Read more about Vecuronium

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.